For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Applications
Doxylamine Succinate - USP Acceptable Modified Method
3274
Separation Mode: Reversed Phase
Reversed Phase
USP L07
C8(2)
HPLC
Histamine H1 Antagonists
Pharmaceutical
Therapeutic / Clinical

Applications

Doxylamine Succinate - USP Acceptable Modified Method
Analytes
1Doxylamine succinate
Compound Name
Doxylamine Succinate
CID
11224
Molecular Formula
C21H28N2O5
Molecular Weight
388
No. Chiral Centers:
1
No. Hydrogen Bond Acceptors
7
No. Hydrogen Bond Donors
2
Details
Official Method: USP L07
LC Conditions (App ID: 3274)
Column:
Brand Name:
Part No:
Phase Name:
C8(2)
Elution Type:
Isocratic
Mobile Phase:
A: Acetonitrile
B: Water with 25mM Potassium phsophate, 10mM Triethylamine, and 5mM Sodium lauryl sulfate
Gradient Profile:
Step No.Time(min)%A%B
103763
Flow Rate:
1.5 mL/min
Temperature:
22°C
Detection:
UV-Vis Abs.-Variable Wave.(UV) @ 262 nm (22°C)
Sample Note:
SecurityGuard™ Guard Cartridge System extends column lifetime. - SecurityGuard Cartridges, C8 4 x 3.0mm, 10/Pk Part No.: AJ0-4290 - Holder Part No.: KJ0-4282

Order Items Used in This Application

Similar Applications
search
No Data